Showing results (51-60 of 203) with videos related to

Sort By:
Pageof 21
Pharmacoepidemiology and Drug Safety|September 29, 2018
Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription dataRebecca M Joseph, Tjeerd P van Staa, Mark Lunt, et al.
Rheumatology (Oxford, England)|August 27, 2009
Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activityKimme L Hyrich, Chris Deighton, Kath D Watson, et al.
Pharmacoepidemiology and Drug Safety|August 7, 2019
Comparison of alternative approaches to trim subjects in the tails of the propensity score distributionRobert J Glynn, Mark Lunt, Kenneth J Rothman, et al.
Pharmacoepidemiology and Drug Safety|January 31, 2023
"Take up to eight tablets per day": Incorporating free-text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiologyMeghna Jani, Belay Birlie Yimer, David Selby, et al.
Rheumatology (Oxford, England)|May 15, 2024
Potential impact of European Medicines Agency measures to minimize risk of serious side effects on JAKi prescribing and utilization in the UKZixing Tian, Lianne Kearsley-Fleet, James Galloway, et al.
The Journal of Rheumatology|March 17, 2019
Effect of Timing and Duration of Statin Exposure on Risk of Hip or Knee Revision Arthroplasty: A Population-based Cohort StudyMichael J Cook, Antony K Sorial, Mark Lunt, et al.
Community Dentistry and Oral Epidemiology|February 24, 2005
Development and validation of the Manchester orofacial pain disability scaleVishal R Aggarwal, Mark Lunt, Joanna M Zakrzewska, et al.
Arthritis Research & Therapy|July 29, 2021
Distinct patterns of disease activity over time in patients with active SLE revealed using latent class trajectory modelsJohn A Reynolds, Jennifer Prattley, Nophar Geifman, et al.
BMJ Open|September 9, 2019
Analysis of English general practice level data linking medication levels, service activity and demography to levels of glycaemic control being achieved in type 2 diabetes to improve clinical practice and patient outcomesAdrian Heald, Mark Davies, Mike Stedman, et al.
Rheumatology Advances in Practice|November 11, 2024
Use of over-the-counter supplements, sleep aids and analgesic medicines in rheumatology: results of a cross-sectional surveyMehreen Soomro, Stephanie Lyons, Ramiro Bravo, et al.
Pageof 21